FR2807757B1 - Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques - Google Patents

Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques

Info

Publication number
FR2807757B1
FR2807757B1 FR0005005A FR0005005A FR2807757B1 FR 2807757 B1 FR2807757 B1 FR 2807757B1 FR 0005005 A FR0005005 A FR 0005005A FR 0005005 A FR0005005 A FR 0005005A FR 2807757 B1 FR2807757 B1 FR 2807757B1
Authority
FR
France
Prior art keywords
neurological
cancers
diagnosis
therapy
novel human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0005005A
Other languages
English (en)
Other versions
FR2807757A1 (fr
Inventor
Michele Aguera
Jean Christophe Antoine
Marie Francoise Belin
Jerome Honnorat
Veronique Rogemond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0005005A priority Critical patent/FR2807757B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to PCT/FR2001/000589 priority patent/WO2001064737A1/fr
Priority to DE60121735A priority patent/DE60121735D1/de
Priority to ES01911811T priority patent/ES2269353T3/es
Priority to DE60121735T priority patent/DE60121735T4/de
Priority to US10/220,042 priority patent/US7329499B2/en
Priority to CA2401438A priority patent/CA2401438C/fr
Priority to AT01911811T priority patent/ATE334145T1/de
Priority to EP01911811A priority patent/EP1263784B1/fr
Priority to JP2001564230A priority patent/JP4990459B2/ja
Publication of FR2807757A1 publication Critical patent/FR2807757A1/fr
Application granted granted Critical
Publication of FR2807757B1 publication Critical patent/FR2807757B1/fr
Priority to US12/068,686 priority patent/US8377645B2/en
Priority to US13/741,876 priority patent/US10087220B2/en
Priority to US16/129,279 priority patent/US20190119339A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
FR0005005A 2000-02-29 2000-04-18 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques Expired - Fee Related FR2807757B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR0005005A FR2807757B1 (fr) 2000-04-18 2000-04-18 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques
AT01911811T ATE334145T1 (de) 2000-02-29 2001-02-28 Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen
ES01911811T ES2269353T3 (es) 2000-02-29 2001-02-28 Nueva proteina ulip/crmp humana y su utilizacion en el diagnostico y la terapia de canceres y de sindromes neurologicos paraneoplasicos.
DE60121735T DE60121735T4 (de) 2000-02-29 2001-02-28 Neues menschliches ULIP/CRMP-Protein und seine Verwendung bei der Diagnose und Behandlung von Krebsen und paraneoplastischen neurologischen Syndromen
US10/220,042 US7329499B2 (en) 2000-02-29 2001-02-28 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
CA2401438A CA2401438C (fr) 2000-02-29 2001-02-28 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
PCT/FR2001/000589 WO2001064737A1 (fr) 2000-02-29 2001-02-28 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
EP01911811A EP1263784B1 (fr) 2000-02-29 2001-02-28 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
JP2001564230A JP4990459B2 (ja) 2000-02-29 2001-02-28 新規ヒトｕｌｉｐ／ｃｒｍｐタンパク質と癌及び傍新形成性神経症候群の診断及び治療におけるその使用
DE60121735A DE60121735D1 (de) 2000-02-29 2001-02-28 Neues menschliches ulip/crmp protein und seine verwendung zur diagnose zur behandlung von krebs und von neurologischen paraneoplastischen syndromen
US12/068,686 US8377645B2 (en) 2000-02-29 2008-02-11 Diagnosis of cancers and paraneoplastic neurological syndromes with novel human ULIP/CRMP protein
US13/741,876 US10087220B2 (en) 2000-02-29 2013-01-15 Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
US16/129,279 US20190119339A1 (en) 2000-02-29 2018-09-12 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0005005A FR2807757B1 (fr) 2000-04-18 2000-04-18 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques

Publications (2)

Publication Number Publication Date
FR2807757A1 FR2807757A1 (fr) 2001-10-19
FR2807757B1 true FR2807757B1 (fr) 2004-08-13

Family

ID=8849391

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0005005A Expired - Fee Related FR2807757B1 (fr) 2000-02-29 2000-04-18 Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques

Country Status (1)

Country Link
FR (1) FR2807757B1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques

Also Published As

Publication number Publication date
FR2807757A1 (fr) 2001-10-19

Similar Documents

Publication Publication Date Title
EP1187844A4 (fr) Polymorphisme de carbamyl phosphate synthetase 1 humaine ; methodes diagnostiques et therapeutiques y relatifs
EE200100372A (et) TWEAK-valgu ja TWEAK-valgu retseptori antagonistid ja nende kasutamine immuunhaiguste raviks
NO20034855L (no) Behandling og diagnose av makrofagmediert sykdom
DE69728323D1 (de) Variante des humanen C3a Rezeptors; diagnostische und therapeutische Verwendungen
NO20022974L (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
IL160917A0 (en) Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
IS4416A (is) Líkamsþyngdarstillar (modulators), samsvarandi kjarnsýrur og prótein, og notkun þeirra við sjúkdómsgreiningar og í læknismeðhöndlun
ATE229815T1 (de) In vitro methoden und verwendung von pharmazeutische zusammensetzungen für die behandlung von innenohrhaarzellen
IS6965A (is) Ganglíósíð-tengd raðbrigða mótefni og notkun þeirra í sjúkdómsgreiningu og meðferð á æxlum
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE60019814D1 (de) Pharmazeutische kombinationen enthaltend tegaserod und omeprazole und ihre verwendung zur behandlung gastrointestinaler krankheiten
FR2766192B1 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
DE69531004D1 (de) p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES
FR2759701B1 (fr) Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
EP1421104A4 (fr) Proteines de zone pellucide humaine et methodes d'utilisation associees pour le diagnostic de la sterilite masculine
EP1491210A4 (fr) Medicament therapeutique comprenant des nanoparticules proteiques creuses presentant un anticorps et nanoparticules proteiques creuses
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
EP1532162A4 (fr) Les cc49, anti-tag-72 humanises servant au diagnostic et au traitement de tumeurs chez l'homme
EP1377287A4 (fr) Proanthocyanidines destinees au traitement des amyloses et des maladies induites par alpha-synucleine
EP1575993A4 (fr) Methodes de traitement de patients et d'identification de therapeutique
FR2805540B1 (fr) Nouvelle proteine ulip humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
FR2845991B1 (fr) Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
FI973185L (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
FR2807757B1 (fr) Nouvelle proteine ulip/crmp humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques et paraneoplastiques
EP1038958A4 (fr) PROTEINE Nap1 HUMAINE

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081231